文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

欧洲专家对小细胞肺癌脑转移治疗决策的多学科分析

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts.
PubMed 文献 · Radiother Oncol · 2020-04-20

该研究分析13名IASLC选出的肿瘤内科医生和13名ESTRO选出的放射肿瘤医生对小细胞肺癌脑转移的管理策略,并将个体决策转化为决策树分析共识。结果显示无症状患者最常推荐单纯化疗,有症状患者最常推荐全脑放疗后化疗,专家间决策存在显著差异。

要点

  • 无症状小细胞肺癌脑转移患者首选单纯化疗。
  • 有症状患者最常推荐全脑放疗后化疗。
  • 内科与放疗科专家对无症状有限脑转移的决策偏好存在差异。

核心结论

  • 欧洲小细胞肺癌专家对小细胞肺癌脑转移一线治疗的临床决策存在显著差异。

研究设计与样本

  • 分析13名由IASLC选出的肿瘤内科医生和13名由ESTRO选出的放射肿瘤医生对小细胞肺癌脑转移的管理策略。
  • 将个体专家的管理策略转化为决策树并进行共识分析。

主要发现

  • 无症状患者最常推荐的一线治疗为单纯化疗。
  • 无症状且脑转移体积有限的患者中,肿瘤内科医生比放射肿瘤医生更倾向于化疗不加全脑放疗。
  • 有症状患者最常推荐全脑放疗后化疗。
  • 有症状且脑转移范围有限时,部分专家选择立体定向放疗作为全脑放疗的替代。

临床怎么用

  • 无症状小细胞肺癌脑转移可考虑单纯化疗作为一线治疗。
  • 有症状患者可考虑全脑放疗后化疗。
  • 有症状且脑转移范围有限时可考虑立体定向放疗替代全脑放疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Brain metastases (BM) are common in patients with small cell lung cancer (SCLC). In recent years, the role of whole brain radiotherapy (WBRT) for brain metastases in lung cancer is being reevaluated, especially in the context of new systemic treatments available for SCLC. With this analysis, we investigate decision-making in SCLC patients with BM among European experts in medical oncology and radiation oncology. METHODS: We analyzed decision-making from 13 medical oncologists (selected by IASLC) and 13 radiation oncologists (selected by ESTRO) specialized in SCLC. Management strategies of individual experts were converted into decision trees and analyzed for consensus. RESULTS AND CONCLUSION: In asymptomatic patients, chemotherapy alone is the most commonly recommended first line treatment. In asymptomatic patients with limited volume of brain metastases, a higher preference for chemotherapy without WBRT among medical oncologists compared to radiation oncologists was observed. For symptomatic patients, WBRT followed by chemotherapy was recommended most commonly. For limited extent of BM in symptomatic patients, some experts chose stereotactic radiotherapy as an alternative to WBRT. Significant variation in clinical decision-making was observed among European SCLC experts for the first line treatment of patients with SCLC and BM.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Putora PM, Fischer GF, Früh M, et al. Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts. Radiother Oncol. 2020. PMID: 32445987. doi:10.1016/j.radonc.2020.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。